IPO
4TEEN4 Pharmaceuticals GmbH announced the closing of a EUR 6.9 million Series A financing round.
Fundraising will support the expansion of Hummingbird Bioscience’s discovery pipeline and rapid development of its portfolio of targeted antibody therapeutics
Bpifrance and Pfizer Ventures co-led international investor syndicate
The company will further develop its high-resolution spinal cord stimulation focal pain therapy and perform clinical studies
Since its foundation Cambridge Innovation Capital has attracted £1 billion of investment into Cambridge companies, highlighting its dominant position at the heart of the innovation ecosystem
Vivoryon Therapeutics AG, announced its third quarter business update for the period ending September 30, 2019.
Liminal BioSciences Inc. has announced that it has closed on the previously announced divestment of its Isle of Man-based bioseparations business operated through its subsidiary Prometic Bioseparations Ltd. (“PBL”) to KKR & Co., a leading global investment firm (“KKR”).
Kane Biotech Inc., a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, announced that that it has engaged Kilmer Lucas Inc. to provide the Company with select U.S. and Canadian investor relations and strategic advisory services..
Mesoblast Limited reported operational highlights and financial results for the first quarter ended September 30, 2019.
Galapagos NV announces a share capital increase arising from warrant exercises.
PRESS RELEASES